CIRCULATING MICRO-RNA (miRNA) AND AR-V7 MUTATIONAL STATUS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (CRPC): PRIMERA+ STUDY (PROSTATE CANCER INNOVATING MARKERS OF EXPECTED RESPONSE TO AGONIST LHRH+ ANDROGEN RECEPTOR INHIBITION
Clinical trial NCT04188275 · UNKNOWN
Trial details
- NCT number
- NCT04188275
- Sponsor
- Azienda Ospedaliero-Universitaria Careggi
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-12-01
- Primary completion
- 2020-06-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.